By Jessica Neuman – UC Irvine News –
World’s first neural stem cell phase 1b/2a clinical trial for condition leverages innovative technology
UCI Health, the clinical enterprise of the University of California, Irvine, has opened the world’s first in-human embryonic stem cell-derived clinical trial for Huntington’s disease.
The phase 1b/2a trial will evaluate the safety of hNSC-01 neural stem cells derived from embryonic stem cells, which are precisely delivered to the brain by a specialized neurological mapping and targeting stereotactic system and performed in an MRI suite.
